2-n-propyl-5-phenylpentanoic acid | 93273-42-8

• 分子结构分类: 有机化合物 - 脂质和类脂质分子 - 脂肪酰基
• 英文名称: 2-n-propyl-5-phenylpentanoic acid
• 英文别名: 2-(3-phenylpropyl)pentanoic acid；5-phenyl-2-propylpentanoic acid
• CAS: 93273-42-8
• 化学式: C₁₄H₂₀O₂
• 分子量: 220.312
• InChiKey: KLVBBRCKPYZPRJ-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  4
• 重原子数：
  16
• 可旋转键数：
  7
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.5
• 拓扑面积：
  37.3
• 氢给体数：
  1
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  2-n-propyl-5-phenylpentanoic acid 在 盐酸 、 PPA 、 汞 、 锌 作用下， 生成 6-n-propylbenzocycloheptane
  参考文献：
  名称：

  Sen, P. K.; Lahiri, Sikha; Das, Tapan K., Indian Journal of Chemistry - Section B Organic and Medicinal Chemistry, 1984, vol. 23, # 9, p. 821 - 824

  摘要：

  DOI：
• 作为产物：
  描述：

  苯 在 氢氧化钾 、 三氯化铝 、 肼 作用下， 以 乙二醇 为溶剂， 生成 2-n-propyl-5-phenylpentanoic acid
  参考文献：
  名称：

  Sen, P. K.; Lahiri, Sikha; Das, Tapan K., Indian Journal of Chemistry - Section B Organic and Medicinal Chemistry, 1984, vol. 23, # 9, p. 821 - 824

  摘要：

  DOI：

文献信息

• CARBOXYLIC DERIVATIVES FOR USE IN THE TREATMENT OF CANCER
  申请人：Aymami Bofarull Juan

  公开号：US20110105544A1

  公开（公告）日：2011-05-05

  The invention provides novel compounds of formula (I), wherein: R 1 is a radical derived from one of the known ring systems; R 2 is a phenyl radical optionally substituted; X n represents a birradical selected from the group consisting of: —(CH 2 ) 1-4 —, (C 2 -C 4 )-alkenyl, (C 2 -C 4 )alkynyl, —S—(CH 2 ) 1-3 —#, and —(CH 2 ) 1-3 —O—#; wherein the symbol # indicates the position at which X n is attached to R 1 ; Y n is a birradical selected from the group consisting of: —(CH 2 ) 2-4 —, —S—(CH 2 ) 1-3 #, and —O—(CH 2 ) 1-3 —#; wherein the symbol # indicates the position at which Y n is attached to R 2 ; and R 3 is a radical selected from the group consisting of: —OR 4 . The compounds of formula (I) are useful in the treatment of cancer.

  本发明提供了式（I）的新化合物，其中：R1是从已知环系中派生的基团；R2是可选取代的苯基基团；Xn代表从以下群组中选择的双基团：—（CH2）1-4—，（C2-C4）-烯基，（C2-C4）炔基，—S—（CH2）1-3—#，和—（CH2）1-3—O—#；其中符号#表示Xn连接到R1的位置；Yn代表从以下群组中选择的双基团：—（CH2）2-4—，—S—（CH2）1-3#，和—O—（CH2）1-3—#；其中符号#表示Yn连接到R2的位置；R3是从以下群组中选择的基团：—OR4。式（I）的化合物在癌症治疗中有用。
• NERVE REGENERATION PROMOTERS
  申请人：ONO PHARMACEUTICAL CO., LTD.

  公开号：EP1685832A1

  公开（公告）日：2006-08-02

  A nerve regeneration which comprises a compound is represented by formula (I): (wherein all symbols are shown in the description), a salt thereof or a prodrug thereof. The compound of the present invention is suppresses nerve cell death as a substance for accelerating growth and/or differentiation of stem cells (nerve stem cells, embryonic stem cells, bone marrow cells, etc.), a substance for accelerating growth and/or differentiation of nerve precursor cells, a potentiator for neurotrophic factor activity, a neurotrophic factor-like substance or a neurodegenerative suppressor, and accelerates repair and regeneration of nerve tissues by neogenesis, regeneration and/or axon evolution. In addition, the compound of the present invention is useful for preparation from brain tissues, bone marrow and/or embryonic stem cells of cells for transplant (nerve stem cells, nerve precursor cells, nerve cells, etc.) and also accelerates grafting, growth, differentiation and/or function expression of cells for transplant whereupon it is useful for prevention and/or treatment of neurodegenerative diseases.

  由式 (I) 所表示的化合物组成的神经再生剂： (其中所有符号均在描述中显示）、其盐或其原药。本发明化合物可抑制神经细胞死亡，可作为加速干细胞（神经干细胞、胚胎干细胞、骨髓细胞等）生长和/或分化的物质、加速神经前体细胞生长和/或分化的物质、神经营养因子活性增效剂、神经营养因子样物质或神经退行性抑制剂，并通过新生、再生和/或轴突演化加速神经组织的修复和再生。此外，本发明的化合物可用于从脑组织、骨髓和/或胚胎干细胞中制备移植细胞（神经干细胞、神经前体细胞、神经细胞等），还可加速移植细胞的移植、生长、分化和/或功能表达，从而可用于预防和/或治疗神经退行性疾病。
• SEN, P. K.;LAHIRI, SIKHA;DAS, TAPAN, K., INDIAN J. CHEM., 1984, 23, N 9, 821-824
  作者：SEN, P. K.、LAHIRI, SIKHA、DAS, TAPAN, K.

  DOI：——

  日期：——
• Pentanoic acid derivatives
  申请人：ONO PHARMACEUTICAL CO., LTD.

  公开号：EP0632008B1

  公开（公告）日：1998-02-04
• Nerve regeneration promoters
  申请人：Tateishi Narito

  公开号：US20070043114A1

  公开（公告）日：2007-02-22

  A nerve regeneration which comprises a compound is represented by formula (I): (wherein all symbols are shown in the description), a salt thereof or a prodrug thereof. The compound of the present invention is suppresses nerve cell death as a substance for accelerating growth and/or differentiation of stem cells (nerve stem cells, embryonic stem cells, bone marrow cells, etc.), a substance for accelerating growth and/or differentiation of nerve precursor cells, a potentiator for neurotrophic factor activity, a neurotrophic factor-like substance or a neurodegenerative suppressor, and accelerates repair and regeneration of nerve tissues by neogenesis, regeneration and/or axon evolution. In addition, the compound of the present invention is useful for preparation from brain tissues, bone marrow and/or embryonic stem cells of cells for transplant (nerve stem cells, nerve precursor cells, nerve cells, etc.) and also accelerates grafting, growth, differentiation and/or function expression of cells for transplant whereupon it is useful for prevention and/or treatment of neurodegenerative diseases.